Tower Research Capital LLC (Trc) Nex Immune, Inc. Transaction History

Tower Research Capital LLC (Trc)

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.2 - $0.3 $0 - $0	-2 Reduced 0.03%	6,390 $1,000
Q2 2023 Aug 14, 2023	SELL	$0.26 - $0.47 $31 - $57	-123 Reduced 1.89%	6,392 $1,000
Q1 2023 May 09, 2023	SELL	$0.3 - $0.6 $5 - $11	-19 Reduced 0.29%	6,515 $2,000
Q4 2022 Feb 10, 2023	SELL	$0.21 - $18.5 $1,551 - $136,659	-7,387 Reduced 53.06%	6,534 $2,000
Q3 2022 Nov 10, 2022	BUY	$0.6 - $17.5 $5,740 - $167,440	9,568 Added 219.8%	13,921 $8,000
Q2 2022 Aug 15, 2022	SELL	$1.61 - $4.68 $2,848 - $8,278	-1,769 Reduced 28.9%	4,353 $7,000
Q1 2022 May 12, 2022	BUY	$1.79 - $4.65 $5,896 - $15,317	3,294 Added 116.48%	6,122 $26,000
Q4 2021 Feb 14, 2022	BUY	$4.11 - $15.13 $9,485 - $34,920	2,308 Added 443.85%	2,828 $13,000
Q3 2021 Nov 15, 2021	SELL	$10.32 - $16.9 $8,844 - $14,483	-857 Reduced 62.24%	520 $8,000
Q2 2021 Aug 16, 2021	BUY	$14.98 - $23.89 $17,032 - $27,162	1,137 Added 473.75%	1,377 $22,000
Q1 2021 May 17, 2021	BUY	$17.95 - $25.91 $4,308 - $6,218	240 New	240 $5,000

Ticker NEXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,155,600
Market Cap $6.04M
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.